Noroviren: häufigste Ursache infektiöser Gastroenteritiden

• Literatur

• 1 Adler JL, Zicki R. Winter vomiting disease. J Infect Dis 1969; 119: 668-673
• 2 Glass RI, Noel J, Ando T et al. The epidemiology of enteric caliciviruses from humans: A reassessment using new diagnostics. Infect Dis 2000; 181: S254
• 3 Gordon I, Ingraham HS, Korns RF. Transmission of epidemic gastroenteritis to human volunteers by oral administration of fecal filtrates. J Exp Med 1947; 86: 409-422
• 4 Jansen A, Beyer A, Brandt C et al. The norovirus-epidemic in Berlin - clinic, epidemiology, and prevention. Z Gastroenterol 2004; 42: 311-316
• 5 Johnston CP, Qiu H, Ticehurst JR et al. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis 2007; 45: 534-40
• 6 Hutson AM, Atmar RL, Estes ME. Norovirus diseases: changing epidemiology and host susceptibility factors. Trends in Microbiology 2004; 12: 279-287
• 7 Kaplan JE, Feldman R, Campbell DS et al. The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health 1982; 72: 1329-1332
• 8 Kapikian AZ, Wyatt RG, Dolin R et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 1972; 10: 1075-1081
• 9 Kaufman SS, Chatterjee NK, Fuschino ME. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant 2003; 3: 764-768
• 10 Lindesmith L, Moe C, Marionneau S et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9: 548-553
• 11 LoBue AD, Lindesmith L, Yount B et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 2006; 24: 5220-5234
• 12 Lopman BA, Brown DW, Koopmans M. Human caliciviruses in Europe. J Clin Virol 2002; 24: 137-160
• 13 Lopman B, Vennema H, Kohli E. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004; 363: 682-689
• 14 Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607-625
• 15 Nicollier-Jamot B, Ogier A, Piroth L et al. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2- like immune responses. Vaccine 2004; 12: 1079-1086
• 16 Reimann HA, Price AH, Hodges JH. The cause of epidemic diarrhea, nausea and vomiting (Viral dysentery?).. Proc Soc Exp Biol Med 1945; 59: 8-9
• 17 Schwartz S, Vergoulidou M, Schreier E et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 2011; 117: 5850-5856
• 18 Tacket CO, Sztein MB, Losonsky GA et al. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 2003; 108: 241-247
• 19 Atmar RL, Bernstein DI, Harro CD et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011; 365: 2178-87